Increased nitric oxide activity in a rat model of acute pancreatitis

Gut

Volumn 43, Issue 4, 1998, Pages 564-570

  Al Mufti, R A ^a   Williamson, R C N ^a   Mathie, R T ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute pancreatitis; Caerulem induced pancreatitis; Inducible nitric oxide synthase; Nitric oxide; Peroxynitrite

Indexed keywords

3 NITROTYROSINE; CERULETIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031706527     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.4.564     Document Type: Article

References (45)

1. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology 1996;110:639-12.
2. Grewal HP, Malak K, El Din AM, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115:213-21.
3. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1994;117:648-55.
4. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966-70.
5. Heath DI, Cruickshank OH, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
6. Viedma JA, Perez-Mateo M, Dominguez JE, et al. Role of interleukin-b in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33: 1264-7.
7. Windsor JA, Fearon KCH, Ross JA, et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 1993;80:1042-6.
8. De Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-53.
9. McKay CJ, Gallagher G, Brooks B, et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83:919-23.
10. Davies MG, Hagen P-O. Systemic inflammatory response syndrome. Br J Surg 1997;84:920-35.
11. Burrell R. Human responses to bacterial endotoxin. Circ Shock 1994;43:137-53.
12. Gomez-Jimenez J, Salgado A, Mourelle M, et al. L-arginine: nitric oxide pathway in endotoxaemia and human septic shock. Crit Care Med 1995;23:253-8.
13. Fahey TJ, Yoshioka T, Shires GT, et al. The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin. Ann Surg 1996;223:63-9.
14. Kuo PC, Schroeder RA. The emerging multifaceted roles of nitric oxide. Ann Surg 1995;221:220-35.
15. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
16. Davies MG, Fulton GJ, Hagen P-O. Clinical biology of nitric oxide. Br J Surg 1995;82:1598-610.
17. Billiar TR. Nitric oxide. Novel biology with clinical relevance. Ann Surg 1995;221:339-49.
18. Calver A, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 1993;78:303-26.
19. Rodeberg DA, Chaet MS, Bass RC, et al. Nitric oxide: an overview. Am J Surg 1995;170:292-303.
20. Szabó S, Salzman AL, Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 1995;363:235-8.
21. Ischiropoulos H, Al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 1995;364:279-82.
22. Van Der Vliet A, Eiserich JP, O'Neill CA, et al. Tyrosine modification by reactive nitrogen species. A closer look. Arch Biochem Biophys 1995;319:341-9.
23. Liu X, Nakano I, Yamaguchi H, et al. Protective effect of nitric oxide on development of acute pancreatitis in rats. Dig Dis Sci 1995;40:2162-9.
24. Werner J, Rivera J, Fernandez-del-Castillo C, et al. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 1997;121:23-50.
25. Molero X, Guarner F, Salas A, et al. Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. Gastroenterology 1995;108: 1855-62.
26. Konturek SJ, Szlachcic A, Dembinski A, et al. Nitric oxide in pancreatic secretion and hormone-induced pancreatitis in rats. Int J Pancreatol 1994;15:19-28.
27. Abe T, Shimosegawa T, Satoh A, et al. Nitric oxide modulates pancreatic edema formation in rat caerulein- induced pancreatitis. J Gastroenterol 1995;30:636-42.
28. Lomis TJ, Siffring CW, Chalasani S, et al. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis. Am Surg 1995;61:7-10.
29. Dabrowski A, Gabryelewicz A. Nitric oxide contributes to multiorgan oxidative stress in acute experimental pancreatitis. Scand J Gastroenterol 1994;29:943-8.
30. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch 1977;373:97-117.
31. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87:682-5.
32. Sato K, Miyakawa K, Takeya M, et al. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J Leukoc Biol 1995;57:36-44.
33. Cook HT, Bune AJ, Jansen AS, et al. Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci 1994;87:179-86.
34. MacNaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993;196: 1330-4.
35. Liu SF, Adcock IM, Old RW, et al. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 1996;24:1219-25.
36. Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275:87-90.
37. Hansson GK, Geng YJ, Holm J, et al. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994;180:733-8.
38. Geng YJ, Almqvist M, Hansson GK. cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim Biophys Acta 1994;1218:421-4.
39. Weigert AL, Higa EM, Niederberger M, et al. Expression and preferential inhibition of inducible nitric oxide synthase in aortas of endotoxemic rats. J Am Soc Nephrol 1995;5:2067-72.
40. Kanno K, Hirata Y, Imai T, et al. Regulation of inducible nitric oxide synthase gene by interleukin-1β in rat vascular endothelial cells. Am J Physiol 1994;267:H2318-24.
41. Sweiry JH, Mann GE. Role of oxidative stress in the pathogenesis of acute pancreatitis. Scand J Gastroenterol 1996; 31 (suppl 210):10-15.
42. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25:57-74.
43. Halliwell B. Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 1991;91(suppl 3C):14-22.
44. Foulis AK, Murray WR, Galloway D, et al. Endotoxaemia and complement activation in acute pancreatitis in man. Gut 1982;23:656-61.
45. Exley AR, Leese T, Holliday MP, et al. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.